MedTrace Logo

Defining Core Outcome Sets in Trigeminal Neuralgia

NCT04272385 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2022-02-21

No results posted yet for this study

Summary

The aim of this study is to determine what patients with trigeminal neuralgia (TN), clinicians and researchers in the field, consider to be the most important outcomes to be expected after undergoing treatment for trigeminal neuralgia and how this could be measured in all studies relating to this condition. This would enable different treatments to be compared using the same standards.

Conditions

  • Trigeminal Neuralgia

Interventions

OTHER

Observational

Observational

Sponsors & Collaborators

  • Rosetrees Trust

    collaborator OTHER

  • University College, London

    lead OTHER

Principal Investigators

  • Joanna Zakrzweska, Professor · University College, London

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-02
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04272385 on ClinicalTrials.gov